Clindamycin (Standard), CAS [[18323-44-9]]

Produktübersicht

• Artikelname: Clindamycin (Standard), CAS [[18323-44-9]]
• Artikelnummer: MCE-HY-B1455R
• Hersteller Artikelnummer: HY-B1455R
• Alternativnummer: MCE-HY-B1455R-10MG,MCE-HY-B1455R-25MG,MCE-HY-B1455R-50MG,MCE-HY-B1455R-100MG,MCE-HY-B1455R-5MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

Clindamycin (Standard) is the analytical standard of Clindamycin. This product is intended for research and analytical applications. Clindamycin is an orally active and broad-spectrum bacteriostatic lincosamide antibiotic. Clindamycin can inhibit bacterial protein synthesis, possessing the ability to suppress the expression of virulence factors in Staphylococcus aureus at sub-inhibitory concentrations (sub-MICs). Clindamycin resistance results from enzymatic methylation of the antibiotic binding site in the 50S ribosomal subunit (23S rRNA). Clindamycin decreases the production of Panton-Valentine leucocidin (PVL), toxic-shock-staphylococcal toxin (TSST-1) or alpha-haemolysin (Hla). Clindamycin also can be used for researching malaria[1][2].

Produkteigenschaften

• Molekulargewicht: 424.98
• CAS Nummer: [18323-44-9]
• Formel: C18H33ClN2O5S
• Target-Kategorie: Antibiotic,Bacterial,Parasite,Reference Standards

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference Standards